Ziccum Investor Relations Material
Latest events
Status Update
Ziccum
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Ziccum
Access all reports
Ziccum is a Sweden-based pharmaceutical company specializing in the development of vaccines. It focuses on creating new thermostable versions of vaccines and biologics through its patented drying technology, LaminarPace. This unique method relies on mass transfer instead of heat transfer, enabling the production of particle-engineered, thermostable dry powder biopharmaceuticals. These powders can be easily handled and transported, and they are suitable for novel administration routes, eliminating the need for cold chain logistics. The company is headquartered in Lund, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
ZICC
Country
đžđȘ Sweden